These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39085725)

  • 1. IMPDH2 suppression impedes cell proliferation by instigating cell cycle arrest and stimulates apoptosis in pediatric hepatoblastoma.
    Li L; Wu Y; Huang HT; Yong JK; Lv Z; Zhou Y; Xiang X; Zhao J; Xi Z; Feng H; Xia Q
    J Cancer Res Clin Oncol; 2024 Aug; 150(8):377. PubMed ID: 39085725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer.
    Huang Y; Chan S; Chen S; Liu X; Li M; Zheng L; Dong Z; Yang Z; Liu Z; Zhou D; Zhang X; Zhang B
    J Transl Med; 2024 Feb; 22(1):133. PubMed ID: 38310229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of dishevelled-2 inhibits cell proliferation and invasion in hepatoblastoma.
    Huang S; Chen J; Tian R; Wang J; Xie C; Gao H; Shan Y; Hong J; Zhang Z; Xu M; Gu S
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27032. PubMed ID: 29528187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.
    Fellenberg J; Kunz P; Sähr H; Depeweg D
    PLoS One; 2010 Aug; 5(8):e12179. PubMed ID: 20808934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMPDH2 Positively Impacts the Proliferation Potential of Hepatoblastoma Cells by Activating JunB Signaling Pathway.
    Yuan L; Zeng L; Ye F; Chen K; Chen Z; Li L
    Curr Mol Pharmacol; 2024 Feb; ():. PubMed ID: 38676510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
    Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
    Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach.
    Srinivasan S; Prasad M; Parambil BC; Shrimal A; Gollamudi VRM; Subramani V; Ramadwar M; Khanna N; Baheti AD; Gala K; Patil V; Laskar S; Qureshi S; Chinnaswamy G
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30302. PubMed ID: 37046413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma.
    Beck A; Eberherr C; Hagemann M; Cairo S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
    Cancer Biol Ther; 2016 Nov; 17(11):1168-1176. PubMed ID: 27635950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma.
    Woodfield SE; Shi Y; Patel RH; Chen Z; Shah AP; Srivastava RK; Whitlock RS; Ibarra AM; Larson SR; Sarabia SF; Badachhape A; Starosolski Z; Ghaghada KB; Sumazin P; Annis DA; López-Terrada D; Vasudevan SA
    Sci Rep; 2021 Feb; 11(1):2967. PubMed ID: 33536467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma.
    Xu Y; Zheng Z; Gao Y; Duan S; Chen C; Rong J; Wang K; Yun M; Weng H; Ye S; Zhang J
    Sci Rep; 2017 Apr; 7(1):745. PubMed ID: 28389646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of survivin in hepatoblastoma after chemotherapy.
    Uehara S; Oue T; Kawatsu M; Nara K; Fukuzawa M
    Eur J Pediatr Surg; 2013 Oct; 23(5):400-4. PubMed ID: 23444076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer.
    Zhou L; Xia D; Zhu J; Chen Y; Chen G; Mo R; Zeng Y; Dai Q; He H; Liang Y; Jiang F; Zhong W
    Clin Transl Oncol; 2014 Oct; 16(10):906-13. PubMed ID: 24659377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rg1 impairs homologous recombination repair by targeting CtBP-interacting protein and sensitizes hepatoblastoma cells to DNA damage.
    Zhen N; Jin L; Ma J; Zhu J; Gu S; Wang J; Pan Q; Ni X; Xu M
    Anticancer Drugs; 2018 Sep; 29(8):756-766. PubMed ID: 29952772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2.
    Liu Y; Song J; Liu Y; Zhou Z; Wang X
    J Exp Clin Cancer Res; 2020 Jun; 39(1):101. PubMed ID: 32493490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
    Venkatramani R; Wang L; Malvar J; Dias D; Sposto R; Malogolowkin MH; Mascarenhas L
    Pediatr Blood Cancer; 2012 Sep; 59(3):493-8. PubMed ID: 22190448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells.
    Eberherr C; Beck A; Vokuhl C; Becker K; Häberle B; Von Schweinitz D; Kappler R
    Int J Oncol; 2019 May; 54(5):1853-1863. PubMed ID: 30864675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
    Lieber J; Kirchner B; Eicher C; Warmann SW; Seitz G; Fuchs J; Armeanu-Ebinger S
    Pediatr Blood Cancer; 2010 Dec; 55(6):1089-95. PubMed ID: 20680965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.